Abstracts Archive - Page 403 of 1683 - ATC Abstracts

2020 American Transplant Congress
Outcomes of Kidney Transplantation in Patients with Sickle Cell Disease and Trait
G. Katz-Greenberg, F. Hailemariam, P. Singh, A. Yadav
Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA
*Purpose: Sickle cell disease (SCD) is an autosomal recessive hematological disorder caused by point mutation (substitution of valine for glutamine). There are about 100,000 patients…
2020 American Transplant Congress
Recurrence of IgA Nephropathy after Kidney Transplantation – Tango Multicenter Study
A. Uffing¹, P. Cravedi², L. V. Riella¹
¹Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Icahn School of Medicine at Mount Sinai, New York, NY
*Purpose: In patients with IgA nephropathy as the cause of ESKD, IgA deposits can recur in the transplanted kidney. However,the incidence and clinical impact of…
2020 American Transplant Congress
Effects of Kidney Transplantation on Cystogenesis in Kidneys Procured from a Deceased Donor with Autosomal Dominant Polycystic Kidney Disease
M. C. Chumley¹, H. Kim², D. M. Williams³, V. Kumar³, M. Mrug³
¹University of Alabama at Birmingham, Birmingham, AL, ²Radiology, University of Alabama at Birmingham, Birmingham, AL, ³Nephrology, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients are not routinely considered as kidney donors for renal transplantation. This is partially due to a concern…
2020 American Transplant Congress
Kidney Transplant from Sickle Cell Donors
P. Vaitla, F. H. Cabeza Rivera, W. Cheungpasitporn, F. Koller, P. Matemavi, J. Wynn
University of Mississippi, Jackson, MS
*Purpose: Patients with End-stage renal disease have an increased risk of death. Dialysis and kidney transplantation are the only treatments. Patients who receive kidney transplantation…
2020 American Transplant Congress
Elucidating the Genetic Background of End Stage Renal Disease of Unknown Aetiology in Patients Listed for Kidney Transplantation
E. Leenen¹, B. Beck², A. Joerres¹, A. Weidemann¹
¹Department of Medicine I - Nephrology, Transplantation & Medical Intensive Care, Medical Center Cologne-Merheim, Cologne, Germany, ²Institute of Human Genetics University Hospital Cologne, Medical Center Cologne-Merheim, Cologne, Germany
*Purpose: The prevalence of end stage renal disease (ESRD) of unknown aetiology in adult patients accounts for almost 20% of all dialysis patients in Europe.…
2020 American Transplant Congress
Deceased Donor Body Temperature is Associated with Delayed Graft Function in Kidney Transplant Recipients
J. Mancinelli¹, N. Mahmud², L. Krumeich¹, M. Harhay³, P. P. Reese⁴, D. Goldberg⁵, P. Abt⁶
¹Department of Surgery, University of Pennsylvania, Philadelphia, PA, ²Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, ³Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, ⁴Renal-Electrolyte and Hypertension Division, Department of Medicine, Center for Clinical Epidemiolog, University of Pennsylvania, Philadelphia, PA, ⁵Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami, Miami, FL, ⁶Division of Transplant Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA
*Purpose: Delayed graft function (DGF) among kidney transplant recipients complicates the post-operative course and is associated with graft failure. Intentional cooling of the donor may…
2020 American Transplant Congress
Organ Offer Behavioral Research Enhances Transplant Surgeon Training
T. S. Diwan¹, D. Stewart², K. Lindblad², A. Dick³, R. Hirose⁴, L. Ratner⁵
¹Univ of Cincinnati Med Ctr, Cincinnati, OH, ²United Network for Organ Sharing, Richmond, VA, ³Seattle Children's Hospital, Seattle, WA, ⁴UCSF Health, San Francisco, CA, ⁵Columbia Univ/NY Pres Hosp, New York, NY
*Purpose: Due to the complexities of fielding organ offers, the 2019 ASTS 2nd Year Surgical Fellows Symposium’s agenda included multiple sessions devoted to training on…
2020 American Transplant Congress
The Potential Significance of ABO Genotyping for Donor Selection in Kidney Transplantation
Y. Zhou¹, W. Deng¹, Y. Wang¹, N. Cui¹, Y. Wu¹, J. Xu¹, S. Fu¹, L. Xiao¹, H. Liu¹, F. Xiong², Y. Miao¹
¹Department of Organ Trasplantation, Nanfang Hospital, Guangzhou, China, ²Southern Medical University, Guangzhou, China
*Purpose: The ABO blood group system is clinically important in kidney transplantation, but ABO genotyping fails to attract sufficient attention in China. We identified one…
2020 American Transplant Congress
Short Tandem Repeat (STR) Analysis Identifies a Cancer Transmitted from an Organ Donor to 4 Transplant Recipients
M. Park¹, J. Van Ziffle¹, E. Collisson¹, J. Grenert¹, S. Behr¹, A. Gonzalez¹, J. Chou¹, S. Maisel¹, T. Friedlander¹, C. Freise¹, J. Shoji¹, T. Semrad², P. Chin-Hong¹, C. Atreya¹
¹UCSF, San Francisco, CA, ²Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, CA
*Purpose: Organ donors are systematically screened for infection, while screening for malignancy is less rigorous. The true incidence of donor-transmitted malignancies is unknown due to…
2020 American Transplant Congress
New Onset Diabetes after Transplant (NODAT) in Hispanic Kidney Transplant Recipients: A Multi-Center Retrospective Study
R. Alsheikh¹, L. Kodali², O. Alfayez³, M. Alshibani¹, A. Basilim¹, M. Fazel⁴
¹King Abdulaziz University, Jeddah, Saudi Arabia, ²Mayo Clinic, Scottsdale, AZ, ³Qassim University, Buraydah, Saudi Arabia, ⁴University of Arizona, Tucson, AZ
*Purpose: Hispanic ethnicity is one of the reported risk factors for NODAT in kidney transplant recipients (KTR). The purpose of our study is to determine…